rediff.com
Rediff Moneywiz
Home
My Portfolio
My Watchlist
Trends
Market News
Hi Guest
Feedback
Investment Tool
Forex
Indices
Sectors
Mutual Funds
Gainers / Losers
Import Portfolio
All Pages
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Announcements
for
Astrazeneca Pharma India Ltd.
14 Feb
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
12 Feb
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
12 Feb
Announcement under Regulation 30 (LODR)-Newspaper Publication
08 Feb
Outcome Of The Board Meeting Held On Monday, February 8, 2021
06 Feb
Astrazeneca Pharma India Limited Receives Import And Market Permission In Form CT-20 (Subsequent New Drug Approval) From The Drugs Controller General Of India For Dapagliflozin Tablets 10Mg
05 Feb
Announcement under Regulation 30 (LODR)-Newspaper Publication
03 Feb
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
29 Jan
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Monday, February 8, 2021
27 Jan
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
21 Jan
Statement Of Investor Complaints For The Quarter Ended December 2020
View announcements for all companies
Next >
Mutual Fund Selector
Find the fund that is right for you
Buy? Sell? Hold?
Get the Latest Stock Tips